🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of this study is to evaluate the pharmacokinetics (PK...
Status
Completed
Location
Site 01
Start Date
2023-01-24
Trial ID
NCT05712265
Treatments Being Tested
The purpose of this study is to evaluate the effectiveness of repurposed me...
Status
Completed
Location
Lamb Health, LLC
Start Date
2021-06-08
Trial ID
NCT05890586
Treatments Being Tested
CYP2C19 is responsible for the metabolism of approximately 10% of drugs cur...
Status
Unknown
Location
Geneva University Hospitals, HUG
Start Date
2022-04-01
Trial ID
NCT05264142
Treatments Being Tested
The purpose of this study is to evaluate the effectiveness of repurposed me...
Status
Completed
Location
Lamb Health, LLC
Start Date
2022-08-25
Trial ID
NCT05894564
Treatments Being Tested
To investigate the influence of fluvoxamine on the pharmacokinetics of BI 4...
Status
Completed
Location
Humanpharmakologisches Zentrum Biberach
Start Date
2016-08-25
Trial ID
NCT02853136
Treatments Being Tested
The purpose of this study is to evaluate the effectiveness of repurposed me...
Status
Completed
Location
Chandler Regional Medical Center
Start Date
2021-06-08
Trial ID
NCT04885530
Treatments Being Tested
Part 1 will evaluate the effects of KP-001 as an inhibitor of BCRP on the P...
Status
Completed
Location
Parexel International Early Phase Clinical Unit
Start Date
2025-02-13
Trial ID
NCT06821698
Treatments Being Tested
1. To evaluate the pharmacokinetics (PK) of pomalidomide administered with ...
Status
Completed
Location
Covance Research Unit, Inc
Start Date
2012-09-01
Trial ID
NCT01707407
Treatments Being Tested
There is an urgent need to identify effective treatments for SARS-CoV-2 inf...
Status
Completed
Location
Rajvithi Hospital
Start Date
2021-10-01
Trial ID
NCT05087381